Myelodysplastic neoplasms (relapsed/refractory)
Indications: Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration Resistant Prostate Cancer (mCRPC) ,Higher Risk Myelodysplastic Syndrome (HR-MDS)
Drug: Eltanexor
Please visit clinicaltrials.gov for more information about this study
This trial is for eltanexor.
Early Stage | Mid Stage | Late Stage | Commercial |
---|---|---|---|
Early Stage | Mid Stage | Late Stage | Commercial |